ABIOMED Analysis

ABIOMED Stock Analysis Notes

About 97.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 2.75. ABIOMED recorded earning per share (EPS) of 5.83. The entity last dividend was issued on the 29th of October 2010. The firm had 2:1 split on the 2nd of October 2000. Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. Abiomed operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2003 people. For more info on ABIOMED please contact Michael Minogue at 978 777-8411 or go to www.abiomed.com.

ABIOMED Investment Alerts

ABIOMED Thematic Classifications

ABIOMED Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 17.18 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ABIOMED's market, we take the total number of its shares issued and multiply it by ABIOMED's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

ABIOMED Profitablity

The company has Profit Margin (PM) of 0.25 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.23 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.23.

ABIOMED Technical and Predictive Indicators

Stock analysis is the technique used by a trader or investor to examine and evaluate how ABIOMED prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ABIOMED shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as ABIOMED. By using and applying ABIOMED Stock analysis, traders can create a robust methodology for identifying ABIOMED entry and exit points for their positions.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

If you are still planning to invest in ABIOMED check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ABIOMED's history and understand the potential risks before investing.